Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: a living systematic review
K Mackey, VJ King, S Gurley, M Kiefer… - Annals of internal …, 2020 - acpjournals.org
An update is available for this article. Background: The role of angiotensin-converting
enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in coronavirus disease …
enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in coronavirus disease …
Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)
Importance The role of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II
receptor blockers (ARB) in the setting of the coronavirus disease 2019 (COVID-19) …
receptor blockers (ARB) in the setting of the coronavirus disease 2019 (COVID-19) …
Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality
EL Fosbøl, JH Butt, L Østergaard, C Andersson… - Jama, 2020 - jamanetwork.com
Importance It has been hypothesized that angiotensin-converting enzyme inhibitors
(ACEIs)/angiotensin receptor blockers (ARBs) may make patients more susceptible to …
(ACEIs)/angiotensin receptor blockers (ARBs) may make patients more susceptible to …
A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor …
Introduction Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) share their target receptor site with the SARS-CoV-2 virus, that may cause …
blockers (ARBs) share their target receptor site with the SARS-CoV-2 virus, that may cause …
ACEI/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis
X Zhang, J Yu, L Pan, H Jiang - Pharmacological research, 2020 - Elsevier
The effects of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) on the risk of COVID-19 infection and disease progression are yet to be …
blockers (ARBs) on the risk of COVID-19 infection and disease progression are yet to be …
Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis
Importance The chronic receipt of angiotensin-converting enzyme inhibitors (ACEIs) and
angiotensin receptor blockers (ARBs) has been assumed to exacerbate complications …
angiotensin receptor blockers (ARBs) has been assumed to exacerbate complications …
[HTML][HTML] Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Background Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
J Hippisley-Cox, D Young, C Coupland, KM Channon… - Heart, 2020 - heart.bmj.com
Background There is uncertainty about the associations of angiotensive enzyme (ACE)
inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. We studied …
inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. We studied …
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
ME Flacco, CA Martellucci, F Bravi, G Parruti… - Heart, 2020 - heart.bmj.com
Objective It has been hypothesised that the use of ACE inhibitors and angiotensin receptor
blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The …
blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The …
Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID‐19, inflammation level, severity, and death in patients …
An association among the use of angiotensin converting enzyme (ACE) inhibitors and
angiotensin‐receptor blockers (ARBs) with the clinical outcomes of coronavirus disease …
angiotensin‐receptor blockers (ARBs) with the clinical outcomes of coronavirus disease …